The role involves leading strategic sourcing for Phase 2 to marketed assets within the Hematology and Immunology therapeutic areas.
Base: $308,000 - $377,000; Bonus/Equity: Incentive compensation and equity included; Benefits: Comprehensive benefits package described on company website
Must-have
Nice-to-have
Not specified